Akero Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireJan 7 07:00 ET

Akero Therapeutics Insider Sold Shares Worth $280,330, According to a Recent SEC Filing

MT NewswiresJan 6 14:13 ET

BofA Securities Maintains Akero Therapeutics(AKRO.US) With Hold Rating, Announces Target Price $35

Moomoo NewsJan 6 06:31 ET · Ratings

Evercore Maintains Akero Therapeutics(AKRO.US) With Buy Rating, Maintains Target Price $38

Moomoo NewsDec 16, 2024 08:33 ET · Ratings

Possible Bearish Signals With Akero Therapeutics Insiders Disposing Stock

Simply Wall StDec 15, 2024 07:18 ET

Insider Sale: Senior VP of $AKRO (AKRO) Sells 925 Shares

Quiver QuantitativeDec 12, 2024 20:31 ET